Travere Therapeutics Inc
For the period ended Dec 31, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
Trading Arrangements
During the fiscal quarter ended December 31, 2024, our directors and/or officers (as defined in Rule 16a-1(f) under the Exchange Act)adopted, modified orterminated the “Rule 10b5-1 trading arrangements” or “non-Rule 10b5-1 trading arrangements,” as those terms are defined in Regulation S-K, Item 408, set forth below:
Trading Arrangements Adopted:
| Name & Title | Date Adopted | Character of Trading Arrangement (1) | Aggregate Number of Shares of Common Stock to be Sold Pursuant to Trading Arrangement | Expiration Date (2) |
|---|---|---|---|---|
| Timothy Coughlin,member of our Board of Directors | November 15, 2024 | Rule 10b5-1 Trading Arrangement | Up to 40,000 shares (3) | March 31, 2025 |
| Gary Lyons,chair of our Board of Directors | December 17, 2024 | Rule 10b5-1 Trading Arrangement | Up to 8,000 shares (4) | June 6, 2025 |
| Jeffrey Meckler,member of our Board of Directors | December 17, 2024 | Rule 10b5-1 Trading Arrangement | Up to 8,000 shares (4) | June 9, 2025 |
| 1 | Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act (the “Rule”). |
| 2 | Each trading arrangement permits transactions through and including the earlier to occur of (a) the completion of all sales and (b) the date listed in the table. Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” only permits transactions upon expiration of the applicable mandatory cooling-off period under the Rule. |
| 3 | Consists of shares of underlying stock options expiring in March 2025. |
| 4 | Consists of shares of underlying stock options expiring in June 2025. |
Trading Arrangements Modified or Terminated:
None.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.